<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Breast cancer":19,
"Prognosis":13,
"SOX17":1,
"cancer stem-like cells":1,
"epithelial-mesenchymal-transition":1,
"linc00617":1,
"long noncoding RNA":2,
"Adjuvant endocrine therapy":1,
"Leuprorelin acetate 6-month depot":1,
"Luteinizing hormone–releasing hormone agonist":1,
"Ovarian function suppression":1,
"Premenopausal hormone receptor-positive breast cancer":1,
"Anaplastic thyroid carcinoma":4,
"Distant metastases":3,
"Genetic abnormalities":1,
"Poorly differentiated thyroid carcinoma":1,
"Biopsy":3,
"Core-needle biopsy":2,
"Fine-needle aspiration biopsy":2,
"Thyroid· Thyroid lesions":1,
"endoscopic":1,
"retroauricular":1,
"solo-surgeon":1,
"solo-surgery":1,
"thyroidectomy":13,
"Características ultrassonográficas":1,
"Escore":1,
"Malignidade de tireoide":1,
"Nódulo tireoidiano":1,
"Scoring":1,
"Suspeito":1,
"Suspicious":1,
"Thyroid malignancy":2,
"Thyroid nodule":21,
"Ultrasound characteristics":1,
"Copper":1,
"Iron":1,
"Selenium":1,
"Thyroid cancer":77,
"Zinc":1,
"false negative results":1,
"fine-needle aspiration":12,
"sensitivity and specificity":1,
"thyroid nodules":11,
"thyroid surgery":3,
"Alcohols":1,
"Case-control studies":2,
"Risk factors":5,
"Smoking":1,
"Thyroid neoplasms":22,
"ESRD":1,
"TSH":1,
"nodular goiter":2,
"thyroid gland":6,
"urinary iodine excretion":1,
"HISTOPATHOLOGY":2,
"MOLECULAR PATHOLOGY":3,
"Acoustic analysis":1,
"Radioactive iodine therapy":4,
"Total thyroidectomy":6,
"Voice":2,
"Well-differentiated thyroid cancer":1,
"Human herpesvirus 4":1,
"Nasopharynx":2,
"Papillary adenocarcinoma":1,
"Thyroid nuclear factor 1":1,
"Gas inflation":1,
"Single-incision endoscopic thyroidectomy":1,
"Trans-axillary endoscopic thyroidectomy":1,
"(131)I therapy":1,
"2D gamma-camera image":1,
"Activity quantification":1,
"Artefacto en la imagen de gammacámara":1,
"Colimador de alta energía":1,
"Corrector filter":1,
"Cuantificación de la actividad":1,
"Filtro corrector":1,
"Fourier transform":1,
"Gamma camera image artifact":1,
"High-energy collimator":1,
"Imagen de gammacámara 2D":1,
"Terapia con (131)I":1,
"Transformada de Fourier":1,
"Merkel cell carcinoma":1,
"histology":2,
"neuroendocrine carcinoma":2,
"parotid gland":2,
"survival":5,
"I-131":1,
"predictive factors":2,
"thyroglobulin":6,
"thyroid ablation failure":1,
"BRAF":8,
"lncRNA":3,
"migration":5,
"papillary thyroid cancer":22,
"proliferation":7,
"Drainage":1,
"Hematoma":1,
"Surgical outcomes":1,
"Conventional":1,
"Endoscopic thyroidectomy":4,
"Gasless":1,
"Transaxillary":2,
"Hyponatremia":1,
"Hypothyroidism":8,
"RAI therapy":1,
"Hypopharyngeal":1,
"Laryngeal":1,
"Negative predictive value":1,
"Positive predictive value":1,
"Sensitivity":1,
"Specificity":1,
"Thyroid gland invasion":1,
"multicenter study":1,
"multimodal treatment":1,
"prognostic factor":1,
"surgery":7,
"Medullary thyroid carcinoma":5,
"Molecular biology":3,
"Papillary thyroid carcinoma":36,
"Simultaneous tumors":1,
"Hey1":1,
"activated Notch1":1,
"Elastography":4,
"Guidelines":2,
"Prostate cancer":2,
"Shear wave elastography":3,
"Strain elastography":1,
"Transient elastography":1,
"World Federation for Ultrasound in Medicine and Biology":1,
"Carcinoma":9,
"Immunohistochemistry":13,
"Lung":4,
"Pleomorphic carcinoma":1,
"Sarcomatoid carcinoma":1,
"Spindle cell carcinoma":1,
"125I seed brachytherapy":1,
"mucoepidermoid carcinoma":1,
"pediatric":1,
"CXCL1":1,
"CXCR1":1,
"CXCR2":2,
"Cancer stem cells":5,
"IL-8":1,
"Thyroid autoimmunity":1,
"Vitamin D":1,
"Color flow Doppler sonography":1,
"Initial assessment":1,
"Thyrotropin":3,
"ETV6-NTRK3 fusion":1,
"MASC":1,
"cytology":6,
"mammary analog secretory carcinoma":1,
"thyroid":37,
"RET":3,
"RET/PTC":3,
"cabozantinib":2,
"non-small cell lung cancer":3,
"precision medicine":2,
"vandetanib":3,
"Differentiated thyroid cancer":13,
"Excellent response":1,
"Preparation mode":1,
"Remnant ablation":1,
"Risk of recurrence":1,
"Thyroglobulin levels":1,
"Body mass index":1,
"Cancer":14,
"Incidence":4,
"Obesity":1,
"Classification":1,
"Convolutional neural network":1,
"Diagnosis":3,
"Feature extraction":1,
"Ultrasound image":1,
"Cowden syndrome":1,
"PTEN immunohistochemical stain":1,
"clear cell acanthoma":1,
"sebaceous lymphadenoma":1,
"trichilemmoma":1,
"Color Doppler ultrasonography":1,
"Neoplasm metastasis":4,
"Signet-ring-cell carcinoma":1,
"Stomach neoplasm":1,
"18FDG-PET":1,
"Differantiated thyroid cancer":1,
"P53 protein expression":1,
"complications":2,
"pediatrics":1,
"recurrence":7,
"Angiogenesis":1,
"EGFL7":1,
"EGFRvIII":1,
"Glioblastoma":1,
"Heterogeneity":2,
"antithyroglobulin antibodies":1,
"thyroglobulin mass spectrometry":1,
"BRAF mutation":6,
"Warburg effect":1,
"glycolysis":3,
"plump eosinophilic cell":1,
"RAS mutations":1,
"RET/PTC and PAX8/PPAR-gamma chromosomal rearrangements":1,
"benign thyroid lesions":1,
"molecular markers":1,
"brown adipose tissue":1,
"thermogenesis":1,
"thyroid hormone":1,
"thyrotoxicosis":2,
"metastasis":16,
"radioisotopes":1,
"thyroid neoplasm":5,
"ATA risk stratification":2,
"central neck dissection":4,
"disease recurrence":1,
"disease-free survival":2,
"reoperation":2,
"response to therapy":2,
"meta-analysis":9,
"non-total thyroidectomy":1,
"papillary thyroid microcarcinoma (PTMC)":1,
"recurrence rate":1,
"Iodine radioisotopes":1,
"Radiotherapy dosage":1,
"Hürthle cell neoplasm":1,
"PET/CT":2,
"follicular neoplasm":3,
"indeterminate":2,
"131I ablation":1,
"brain glucose metabolism":1,
"positron emission tomography":1,
"Lymph node metastasis":7,
"PNET":1,
"teratoma":1,
"treatment":4,
"tumor sequencing":1,
"TP53":1,
"anaplastic thyroid cancer":7,
"cfDNA":1,
"mutation":3,
"sequencing":1,
"Graves' disease":1,
"Hashimoto's thyroiditis":1,
"lymphocytic thyroiditis":1,
"papillary carcinoma":4,
"antigastric parietal cell antibody":1,
"antithyroglobulin antibody":1,
"antithyroid microsomal antibody":1,
"atrophic glossitis":1,
"recurrent aphthous stomatitis":1,
"follicular adenoma":1,
"follicular thyroid cancer":5,
"follicular variant papillary thyroid carcinoma":1,
"tissue microarray":1,
"Drosophila melanogaster":1,
"animal models":1,
"chick chorioallantoic membrane":1,
"medullary thyroid cancer":5,
"mice":1,
"zebrafish":2,
"VEGFs":1,
"lymphangiogenesis":1,
"nuclear receptor corepressor 1":1,
"thyroid hormone receptor beta 1":1,
"US elastography":1,
"fibronectin-1":1,
"fibrosis":1,
"galectin-3":1,
"indeterminate cytology":1,
"Attention network test":1,
"Endocrine therapy":1,
"Executive function":1,
"Tamoxifen":2,
"Cáncer diferenciado de tiroides":1,
"Defectos embrionarios del tiroides":1,
"Dysembriogenetic thyroid defects":1,
"Ectopic thyroid":2,
"Lingual thyroid":2,
"Quiste tirogloso":1,
"Thyroglossal duct cysts":1,
"Tiroides ectópico":1,
"Tiroides lingual":1,
"cancer biomarkers":1,
"poor prognosis":1,
"thyroid hormone receptor-interacting protein 13":1,
"Brain tumor":1,
"Glioma":3,
"Quality of life":3,
"Thyroid hormones":4,
"Tri-iodothyronine":2,
"Pediatric thyroid cancer":3,
"1,1′-Oxalyldiimidazole (ODI) chemiluminescence":1,
"Biosensor":1,
"Chemiluminescent enzyme immunoassay (CLEIA)":1,
"Nanoparticle":1,
"Stimulant hormone (TSH)":1,
"Tumor marker":1,
"adverse events":2,
"anti-PD1 antibodies":1,
"pruritus":1,
"Exotic cats":1,
"felids":1,
"neoplasia":1,
"parathyroid":2,
"cox regression model":1,
"epidemiology and end results (SEER) database":1,
"propensity score":2,
"surgery and radiation treatment":1,
"thyroid carcinoma":19,
"miR-375":1,
"MicroRNA":3,
"pancreatic ductal adenocarcinoma":1,
"tumor-suppressor ZFP36L2":1,
"BRAF V600E":2,
"WIPF1":1,
"oncogenesis":2,
"tumor aggressiveness":1,
"Differentiated thyroid carcinoma":2,
"Fluorodeoxyglucose-PET/computed tomography":1,
"High thyroglobulin and negative iodine scintigraphy":1,
"PET":1,
"Radioiodine scan":1,
"Radioiodine therapy":2,
"C14orf93":1,
"Exome sequencing":1,
"RTFC":1,
"RET isoforms":1,
"epithelial–mesenchymal transition":1,
"invasion":3,
"CD56, immunohistochemistry":1,
"adenomatous hyperplasia":1,
"extremely well-differentiated":1,
"follicular epithelial dysplasia":1,
"well-differentiated tumors of uncertain malignant potential":1,
"BRAF V600E mutation":2,
"RAS mutation":1,
"TERT promoter mutation":2,
"prognostic molecular markers":1,
"drug resistance":2,
"epithelial-mesenchymal transition":2,
"molecular targeted therapy":2,
"HCC":1,
"HFS":1,
"diarrhoea":1,
"hypertension":3,
"sorafenib":6,
"Cancer signaling":1,
"Estrogen":1,
"Gender medicine":1,
"Anti-NMDA receptor encephalitis":1,
"Differential diagnosis":3,
"Misdiagnosis":1,
"Tumor":1,
"Bethesda category III":1,
"acoustic radiation force impulse elastography":1,
"fine-needle aspiration cytology":1,
"ultrasound":9,
"NONHSAT076754":1,
"biomarker":7,
"ultrasonography":4,
"Betulin":1,
"Renal cell carcinoma":3,
"mTOR":1,
"Health Status Disparities":1,
"Minority Health":1,
"SEER Program":2,
"18F-FDG uptake":2,
"glucose metabolism":1,
"metformin":1,
"breast carcinoma in situ":1,
"outcomes":2,
"tumor subtype":1,
"BDNF":1,
"miR-497":1,
"tumorigenesis":3,
"HIT000218960":1,
"HMGA2":1,
"Anti-cancer":1,
"Apoptosis":3,
"Autophagy":3,
"Honokiol":1,
"Capecitabine":1,
"Chemotherapy":4,
"Cisplatin":1,
"Gastric cancer":1,
"Modified XP regimen":1,
"color Doppler":1,
"fine‐needle aspiration":1,
"head and neck ultrasound":2,
"intranodular vascularity":1,
"thyroid sonography":1,
"genomics":3,
"papillary thyroid carcinmona":1,
"radiation therapy":1,
"sarcoma":3,
"EphB3":1,
"Rho (Rho GTPase)":1,
"Vav2":1,
"cancer biology":3,
"cell migration":1,
"focal adhesion":1,
"quality measurement":1,
"shear wave speed imaging":2,
"differentiation":1,
"gene fusion":1,
"peroxisome proliferator-activated receptor gamma":1,
"pioglitazone":1,
"clinicopathological features":2,
"meta–analysis":1,
"mortality risk":1,
"tall cell variant":1,
"Induction chemotherapy":1,
"S-1":1,
"chemoradiotherapy":2,
"gemcitabine":1,
"pancreatic cancer":1,
"Contrast":1,
"BRAFV600E":2,
"Nthy-ori 3-1 cell":1,
"microarrays":1,
"signal transduction":1,
"Cdc42":1,
"ESCC":1,
"FLNC":1,
"Rac1":1,
"genetics":3,
"miRNA":3,
"predisposition":1,
"variants":1,
"diagnostic meta-analysis":1,
"thyroid stimulating hormone receptor":1,
"PKM2":3,
"ROS":1,
"SIRT5":1,
"succinylation":1,
"tumor growth":1,
"IHC":1,
"OLC1":1,
"gastric adenocarcinoma":1,
"subcellular expression":1,
"AIF = arterial input function":1,
"ASMase = acid sphingomyelinase":1,
"DCE = dynamic contrast-enhanced":1,
"FA = flip angle":1,
"FOV = field of view":1,
"HD IGRT = high-dose image-guided radiation therapy":1,
"Ktrans = vascular permeability":1,
"ROI = region of interest":1,
"Vp = plasma volume":1,
"dynamic contrast-enhanced MRI":1,
"high-dose image-guided radiation therapy":1,
"spine tumor response":1,
"EMT process":1,
"N-cadherin":1,
"major signaling pathways":1,
"National Institutes of Health":1,
"head and neck cancer":1,
"head and neck squamous cell carcinoma":1,
"Lung cancer":4,
"Metastatic vertebral tumor":1,
"Revised Tokuhashi score":1,
"Survival period":1,
"MYH9":1,
"bidirectional promoter":1,
"transcriptional regulation":1,
"age":2,
"cancer cases":1,
"cancer statistics":1,
"death rates":1,
"mortality":1,
"meningioma":1,
"Endoscopy":1,
"Graves’ disease":1,
"Neurosurgery":1,
"Pituitary neoplasms":1,
"TSH-producing tumor":1,
"TSHoma":1,
"miR-221":1,
"Autograft":1,
"Pasteurization":1,
"Periacetabular malignant bone tumour":1,
"Reconstruction":1,
"Epithelial-mesenchymal transition (EMT)":1,
"Estrogen receptor alpha (ERα)":1,
"MAP3K2":1,
"Triple negative breast cancer (TNBC)":1,
"miR-34c-3p":1,
"Aspergilloma":1,
"Case report":2,
"Radioiodine":2,
"SPECT/CT":1,
"Sinus":1,
"Atypical clinical presentation":1,
"Ependymoma":1,
"Filum terminale":1,
"Giant cell":1,
"Immunohistochemistry markers":1,
"Antiangiogenic tyrosine kinase inhibitor":1,
"Lenvatinib":5,
"cancer cell of origin":1,
"cancer genomics":1,
"noncoding genetic variation":1,
"somatic mutational processes":1,
"statistical driver discovery":1,
"variant topography":1,
"whole-genome sequencing":1,
"Thyroxine":1,
"Postoperative pain":1,
"CNB":1,
"FNA":1,
"Chernobyl":1,
"Fukushima":1,
"Radiation":1,
"Ultrasound screening":1,
"Early diagnosis":1,
"Genetic predisposition to disease":1,
"Genetic testing":1,
"Multilocus sequence typing":1,
"Cancer screening":2,
"Overdiagnosis":4,
"Overtreatment":1,
"Computed tomography":2,
"Incidentaloma":2,
"Technetium thyroid uptake":1,
"Thyroid scintigraphy":1,
"Epistasis":1,
"Gene-gene interactions":1,
"Genome-wide association study":1,
"Group Lasso":1,
"HES1":1,
"Tumor progression":1,
"miR-182":1,
"RASSF1A":1,
"methylation":2,
"high-frequency color ultrasonography":1,
"lymph node dissection":1,
"cardiac metastasis":1,
"disseminated intravascular coagulation":1,
"squamous cell carcinoma of the thyroid gland":1,
"PIK3CA":1,
"miR-363-3p":1,
"Papillary thyroid microcarcinoma":5,
"Ultrasonographic features":1,
"coffee":1,
"cohort studies":1,
"review":2,
"Frontal bone":1,
"occult follicular thyroid carcinoma":1,
"skull metastasis":1,
"Bethesda system":3,
"Category III":1,
"substratification":1,
"aneuploidy":2,
"cellsearch":1,
"circulating tumor cells (CTC)":1,
"subtraction enrichment":1,
"Epidermal growth factor receptor":1,
"female":1,
"nonsmall cell lung carcinoma":2,
"reirradiation":1,
"thyroid metastasis":1,
"131I-whole body scan":1,
"18F-fluorodeoxyglucose-positron emission tomography":1,
"follicular variant":1,
"renal metastasis":1,
"terminology":1,
"18-Fluorodeoxyglucose positron emission tomography":1,
"metaiodobenzylguanidine":1,
"neural crest cell tumor":1,
"differentially expressed gene":1,
"latent pathway analysis":1,
"protein-protein interaction network":1,
"significant pathway":1,
"Carcinoma de tiroides":1,
"DNA methylation":1,
"Epigenetics":1,
"Epigenética":1,
"Histone modifications":1,
"Metilación de DNA":1,
"Modificación de histonas":1,
"ectopic":1,
"pleura":1,
"circulating":1,
"follow-up":2,
"neck central lymph node metastasis":1,
"E-cadherin":1,
"serum":1,
"Canada":2,
"Cancer incidence":1,
"First Nations":1,
"Cytokeratin":1,
"isolated skeletal muscle metastasis":1,
"parathyroid hormone related peptide":1,
"skeletal muscle metastasis":1,
"thyroid transcription factor":1,
"ENTPD3":1,
"Extracellular ATP":1,
"GATA3":1,
"Cervical approach":1,
"Ectopic goiter":1,
"Intrathoracic goiter":1,
"Substernal goiter":1,
"Fine needle cytology":1,
"Hemithyroidectomy":2,
"Calcitonin":2,
"Cancer registry":1,
"Database":1,
"RET proto-oncogene":1,
"Biological markers":1,
"Cancer stage":1,
"Iodine":3,
"Radioisotope scintigraphy":1,
"Therapeutic":1,
"Thyroid tumor":1,
"atypia of undetermined significance":2,
"fine needle aspiration":6,
"follicular lesion of undetermined significance":2,
"risk of malignancy":1,
"sub-category":1,
"thyroid cytopathology":1,
"phosphorylation of thyroid hormone receptor β1":1,
"thyroid hormone receptor β mutant":1,
"tumor suppressor":2,
"xenograft models":1,
"liquid based cytology":1,
"paediatric thyroid carcinoma":1,
"paediatric thyroid lesions":1,
"plump cells":1,
"Core needle biopsy":3,
"Malignancy":1,
"Neoplasm":2,
"Larynx chondrosarcoma":1,
"cartilaginous tumor":1,
"chondrosarcomas":1,
"laryngeal cancer":1,
"laryngeal chondrosarcoma":1,
"laryngeal malignancy":1,
"laryngeal tumor":1,
"larynx cancer":1,
"larynx malignancy":1,
"systematic review":1,
"Bilateral axillary approach":1,
"Robotic thyroid surgery":1,
"Robotic thyroidectomy":2,
"OK-432":1,
"Sapylin":1,
"modified radical mastectomy":1,
"postoperative complication":1,
"seroma formation":1,
"EZH2":2,
"RASSF2A":1,
"genitourinary":1,
"thyroid-like follicular carcinoma":1,
"Bethesda criteria":1,
"Bethesda recommendations":1,
"Repeat FNA":1,
"Biliary tract cancer":1,
"Ductal margin":1,
"Frozen section":2,
"TERT mutation":1,
"therapy response":1,
"Risk stratification":2,
"atherosclerosis":2,
"childhood cancer survivors":1,
"intima-media thickness":1,
"late effects":1,
"radiotherapy":4,
"2009 revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer":1,
"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer":1,
"Decision-making":1,
"Differentiated thyroid cancer management guidelines":1,
"Recommendations":1,
"Thyroid remnant ablation":1,
"cancer radiopeptide targeting":1,
"renal cell cancer":1,
"somatostatin sst2 receptors":1,
"sst2 antagonist":1,
"WT1 protein":1,
"calretinin":1,
"carcinoembryonic antigen":1,
"claudin-4":1,
"mesothelioma":1,
"p40":1,
"squamous cell carcinoma":3,
"Thermal ablation":2,
"radiofrequency/microwave":1,
"Hydroxytyrosol":1,
"Nutrition":1,
"Olive oil":1,
"Adult":1,
"Auricular thrombosis":1,
"Rhabdomyosarcoma":1,
"Venous thrombosis":1,
"18F-FDG PET/CT":1,
"Esophageal cancer":1,
"MTV":1,
"TLG":1,
"Texture analysis":1,
"the Bethesda system for reporting thyroid cytopathology":1,
"Concomitant disease":1,
"Parathyroid gland":3,
"Parathyroidectomy":2,
"Iodine deficiency":1,
"Iodised salt":1,
"Seafood nutrition":1,
"Thyroid nodular pathology":1,
"Urinary iodine concentration":1,
"Autoimmune thyroiditis":2,
"Breast surgery":1,
"Breast treatment":1,
"Thyroid disease":1,
"Acromegaly":2,
"Colon":1,
"carbon nanoparticles":1,
"neck lymphadenectomy":1,
"Glande thyroïdienne":1,
"Néoplasmes thyroïdiens":1,
"Surdiagnostic":1,
"airway epithelium":1,
"respiratory function tests":1,
"thoracic surgery":1,
"Long bones":1,
"Metastatic bone disease":1,
"Surgical treatment":1,
"BAVANS":1,
"bidirectional approach":1,
"Cancer thyroïde":1,
"Carcinome mucineux":1,
"Mucin":2,
"Mucine":1,
"Mucinous carcinoma":1,
"TTF1":1,
"Follicular":1,
"Adverse event":1,
"Overall survival":3,
"Recurrence free survival":1,
"Thyroid lobectomy":1,
"ER-α":1,
"PTEN":1,
"glyoxalases":1,
"microvessel density":1,
"vascular endothelial growth factor":2,
"vascular index":1,
"Ganglioneuroma":1,
"multiple endocrine neoplasia type 2B":1,
"paraganglioma":1,
"radioactive iodine-refractory thyroid cancer":2,
"bilaterality":1,
"multifocality":3,
"practice guidelines":1,
"predictive accuracy":1,
"estimation models":1,
"radiation carcinogenesis":1,
"second primary cancer":1,
"lateral lymph node metastasis":1,
"level V dissection":1,
"level V metastasis":1,
"modified radical neck dissection":1,
"clear cell renal cell carcinoma metastases":1,
"contralateral adrenal gland":1,
"cytology diagnosis":1,
"pancreas":1,
"intensity modulated radiotherapy":1,
"locoregional control":1,
"unresectable poorly differentiated thyroid carcinoma":1,
"RAS":2,
"papillary":3,
"cell cycle":2,
"gene expression":3,
"mitotic phase":1,
"translational research":1,
"HNC":1,
"clinical application":1,
"function":1,
"lncRNAs":1,
"mechanism":1,
"epidemiology":2,
"medullary thyroid carcinoma—genetics":1,
"magnetic probe–guided excision":1,
"metastatic lymph nodes":1,
"Mps1":1,
"TTK":1,
"target":1,
"FOXE1 polymorphism":1,
"case-control association study":1,
"functional analysis of transactivation potential":1,
"genotype":1,
"children":2,
"mutations":1,
"clinical research":1,
"Collective cell migration":1,
"Gap junction":1,
"Rac":1,
"Single cell migration":1,
"All-trans retinoic acid (ATRA)":1,
"Drug delivery systems":1,
"Human thyroid carcinoma":1,
"Liposomes":1,
"Aging":1,
"Molecular diagnosis":2,
"AKT pathway":1,
"ERα":1,
"MCAM/CD146":1,
"Tamoxifen resistance":1,
"AGK-BRAF":1,
"ETV6-NTRK3":1,
"pediatric thyroid carcinomas":1,
"metabolic syndrome":2,
"thyroid hormone withdrawal":1,
"Interleukin 10":1,
"Prognostic marker":1,
"Tumor immunology":1,
"shoulder complaints":1,
"SEER":1,
"germ cell tumors":1,
"ovarian cancers":1,
"second cancers":1,
"cervicotomy":1,
"pain":1,
"robot":1,
"Enophthalmos":1,
"Idiopathic orbital inflammatory syndrome":1,
"IgG4-related disease":1,
"Orbit":1,
"Orbital fracture":1,
"Thyroid eye disease":1,
"Traumatic optic neuropathy":1,
"Drug response":1,
"esophageal squamous cell carcinoma":2,
"fibrinogen":1,
"neutrophils":1,
"Benign thyroid nodule":1,
"Microwave ablation":1,
"Radiofrequency ablation":1,
"sonography":1,
"Neuroglioma":1,
"PTPN4 PDZ domain":1,
"Peptide ligand":1,
"Salt bridge":1,
"capsular invasion":1,
"cervical lymph node metastasis":1,
"fine needle aspiration cytology":1,
"IL-27":1,
"risk":1,
"rs153109":1,
"rs17855750":1,
"single nucleotide polymorphism":2,
"fine-needle aspiration (FNA)":1,
"health care costs":1,
"thyroid cancer incidence":1,
"Adhesion":1,
"Renal cancer":1,
"Type 1 iodothyronine deiodinase":1,
"Cadmium":1,
"GPER":1,
"Cancer thyroïdien":1,
"FDG-PET":1,
"FDOPA":1,
"Iode-124":1,
"Iodine-124":1,
"TEP-FDG":1,
"cell signaling":1,
"indoleamine-pyrrole 2,3-dioxygenase (IDO1)":1,
"interferon regulatory factor (IRF)":1,
"signal transducers and activators of transcription 1 (STAT1)":1,
"ancillary test":1,
"multi-institutional":1,
"salivary gland":1,
"Aged":1,
"fine needle aspiration cytology (FNA)":1,
"Depression":1,
"PHQ-9":1,
"Psychosocial oncology":1,
"ATC":1,
"brigatinib":1,
"ceritinib":1,
"crizotinib":1,
"neuroblastom":1,
"14q32 region":1,
"microTranscriptome":1,
"NEAT1":1,
"miR-101":1,
"YAP1":1,
"signaling pathway":2,
"GRP 78":1,
"Heat shock protein 70":1,
"Heat shock protein 90":1,
"Adenocarcinoma":4,
"Subtype":2,
"Thymus":1,
"ROCK":1,
"SP600125":1,
"multi-tyrosine kinase inhibitors":1,
"multicellular spheroids":1,
"Hyperthyroidism":2,
"Nodule":2,
"Breast cancer cell migration":1,
"Focal adhesion complex":1,
"Src/FAK/PI3K":1,
"Triiodothyronine":1,
"solid-organ transplant":1,
"standardized incidence ratio":1,
"TERT":2,
"telomerase":1,
"hobnail":1,
"next-generation sequencing":3,
"CAM assay":1,
"TT cells":1,
"neuroendocrine tumor":1,
"shikonin":1,
"elastic modulus":1,
"Bone tumour":1,
"Massive prosthesis":1,
"Multidisciplinary management":1,
"Pathological fracture":1,
"PD1":1,
"PDL1":1,
"anaplastic carcinoma":1,
"miR-146a":1,
"potassium iodate":1,
"Aggressive behavior":1,
"Primary tumor diameter":1,
"Total tumor diameter":1,
"Tumor diameter ratio":1,
"Hashimoto-thyreoiditis":1,
"Hashimoto’s thyroiditis":1,
"papillaris pajzsmirigy-carcinoma":1,
"cervical lymph nodes":1,
"metastases":2,
"pathology-thyroid":1,
"radiology":1,
"APC mutation":1,
"Colorectal cancer":2,
"Dclk1":1,
"Intestinal epithelial cells":1,
"Nanoparticles":1,
"Pro-survival signaling":1,
"Self-renewal":1,
"Nodules":1,
"Fine-needle":1,
"Health Services Accessibility":1,
"Han Chinese":1,
"SNPs":1,
"VEGFA":1,
"FDG-PET/CT":1,
"neoadjuvant chemoradiotherapy":1,
"EMT":2,
"LncRNA PTCSC3":1,
"Wnt signal":1,
"NIS mutations":1,
"gene transfer studies":1,
"imaging and radioiodide therapy":1,
"sodium/iodide symporter":1,
"structure/function":1,
"IGF1R":1,
"IGF2BP3":1,
"chromosomal rearrangements":1,
"Microcarcinoma":1,
"Drug holiday":1,
"EGFR TKI retreatment":1,
"EGFR mutation":1,
"Exon 21 mutation":1,
"Females":1,
"Progression free survival":1,
"cucurbitacin B":1,
"doxorubicin":1,
"synergism":1,
"Thyroid transcription factor 1":1,
"expression":1,
"Free anteromedial thigh perforator flap":1,
"Relaying anterolateral thigh perforator flap":1,
"Skin transplantation":1,
"Surgical flaps":1,
"Wounds and injuries":1,
"Abnormal thyroid gland":1,
"Piriform fossa":1,
"Thyroid adenoma":1,
"Birt–Hogg–Dubé syndrome":1,
"Lung bubblae":1,
"Pneumothorax":1,
"Immunotherapy":3,
"Myxedema crisis":1,
"Nivolumab":1,
"caveolin-1":2,
"oncogene":1,
"tumor suppressor gene":2,
"Colocalization":1,
"Colorectal":1,
"Tubular adenoma":1,
"Benign mixed parotid tumor":1,
"Facial spasm":1,
"Pleomorphic adenoma":1,
"Reconstructive surgery":1,
"Salivary glands":2,
"Adrenal oncocytoma":1,
"Robotic adenalectomy":1,
"Bleeding macroadenoma":1,
"Oncocytoma adenohypophysis":1,
"Pituitary bleeding":1,
"Pituitary gland":1,
"Rare pituitary neoplasm":1,
"Spindle cell oncocytoma":1,
"Adenoid cystic carcinoma":1,
"Micro papillary thyroid carcinoma":1,
"Stridor":1,
"Trachea":1,
"fine-needle aspirate":1,
"fine-needle aspiration supernatant":1,
"Poly r(C) binding protein":1,
"miR-490-3p":1,
"High resolution melting (HRM) analysis":1,
"Prophylactic central neck dissection":2,
"cN0":1,
"LY3009120":1,
"Obatoclax":1,
"Vemurafenib":2,
"Endometrial neoplasms":1,
"Post-menopausal bleeding":1,
"Leiomyosarcoma thyroid":1,
"Malignant fibrous histiocytoma thyroid":1,
"Sarcoma thyroid":1,
"Thyroid mass lesion":1,
"Benign":1,
"Calcification":1,
"Thyroid parenchyma":1,
"Advanced thyroid cancer":1,
"Tracheal infiltration":1,
"Tyrosine kinase inhibitor":2,
"Biología molecular":1,
"Carcinoma papilar de tiroides":1,
"Inmunohistoquímica":1,
"Mutación BRAF V600E":1,
"PCR en tiempo real":1,
"Real time PCR":1,
"Bone metastases":1,
"temporal":1,
"GH deficiency":1,
"rhGH replacement":1,
"cordectomy":1,
"glottis insufficiency":1,
"thyroplasty":2,
"unilateral vocal fold paralysis":1,
"voice quality":2,
"Clinical outcomes":1,
"Multifocal macroscopic papillary thyroid cancer":1,
"Thyroid cancer recurrence":1,
"intraoperative PTH":1,
"intrathryoidal parathyroid":1,
"parathyroid cancer":1,
"tertiary hyperparathyroidism":1,
"dabrafenib":2,
"radioactive iodine":1,
"AASLD, American Association for the Study of Liver Diseases":1,
"ADV, adefovir dipivoxil":1,
"ALT, alanine aminotransferase":1,
"APASL, Asian Pacific Association for the Study of the Liver":1,
"ART, antiretroviral therapy":1,
"AST, aspartate aminotransferase":1,
"Anti-HBe, antibodies to hepatitis B envelope antigen":1,
"CBC, complete blood count":1,
"CDC, Center for Disease Control":1,
"CHB, chronic hepatitis B":1,
"CU-HCC, Chinese University-Hepatocellular Carcinoma":1,
"DAA, direct-acting antiviral":1,
"DILI, drug induced liver injury":1,
"DNA, deoxyribonucleic acid":1,
"EASL, European Association for the Study of the Liver":1,
"ETV, entecavir":1,
"GAG-HCC, Guide with Age, Gender, HBV DNA, Core Promoter Mutations and Cirrhosis-Hepatocellular Carcinoma":1,
"GGT, gamma-glutamyl transferase":1,
"GRADE, Grading of Recommendations Assessment Development and Evaluation":1,
"HBIG, hepatitis B immune globulin":1,
"HBV, hepatitis B virus":1,
"HBeAg, hepatitis B envelope antigen":1,
"HCC, hepatocellular carcinoma":1,
"HCV, hepatitis C virus":1,
"HDV, hepatitis D virus":1,
"HIV, human immunodeficiency virus":1,
"IFN-α, interferon alpha":1,
"INASL, Indian National Association for Study of the Liver":1,
"INR, international normalized ratio":1,
"KASL, Korean Association for the Study of the Liver":1,
"LAM, lamivudine":1,
"NA, nucleos(t)ide analogue":1,
"PAGE-B, platelets, age, gender—hepatitis B":1,
"PVNR, primary virological non-response":1,
"PVR, partial virological response":1,
"PegIFN-α, pegylated interferon alpha":1,
"RCT, randomized controlled trial":1,
"REACH-B, risk estimation for hepatocellular carcinoma in chronic hepatitis B":1,
"SOVR, sustained off-therapy virological response":1,
"TAF, tenofovir alafenamide":1,
"TDF, tenofovir disoproxil fumarate":1,
"TDV, telbivudine":1,
"TSH, thyroid-stimulating hormone":1,
"VR, virologic response":1,
"WHO, World Health Organization":1,
"anti-HBs, antibody to hepatitis B surface antigen":1,
"cccDNA, covalently closed circular DNA":1,
"chronic hepatitis":1,
"cirrhosis":2,
"eGFR, estimated glomerular filtration rate":1,
"hepatitis B":1,
"jaundice":1,
"liver failure":1,
"MicroPure system with ultrasonography":1,
"monochrome super micro vascular imaging":1,
"Hashimoto's encephalopathy":1,
"¹³¹I radiotherapy":1,
"Cancer progression":1,
"HPV":1,
"Oncology":1,
"dog":1,
"side effect":2,
"cystic degeneration ratio":1,
"fine needle aspiration biopsy":1,
"nodule size":1,
"number of aspirations":1,
"specimen adequacy":1,
"fundamental frequency":1,
"maximal vocal pitch":1,
"non-diagnostic":1,
"Fluorodeoxyglucose F18":1,
"Positron-Emission Tomography":1,
"BABA":1,
"Bilateral axillo-breast approach":2,
"Completeness":1,
"Large thyroid carcinoma":1,
"Robotic":1,
"Esophageal carcinoma":1,
"Lateral pedicle":1,
"Lymphadenectomy":1,
"Pincers maneuver":1,
"Right recurrent laryngeal nerve":1,
"Thoracoscopic esophagectomy in the prone position":1,
"ENDOCRINE PATHOLOGY":1,
"En bloc spondylectomy":1,
"Extirpación radical":1,
"Radical resection":1,
"Spinal tumour":1,
"Surgical technique":1,
"Tomita":1,
"Total vertebrectomy":1,
"Tumor vertebral":1,
"Técnica quirúrgica":1,
"Vertebrectomía en bloque":1,
"Vertebrectomía total":1,
"Central lymph node metastasis":2,
"Carcinoma, Renal Cell":1,
"Carcinoma, squamous cell of head and neck [Supplementary Concept]":1,
"Cribriform-morular variant":1,
"Telomerase reverse transcriptase":1,
"axial shear strain":1,
"axial strain":1,
"cancer imaging":1,
"interstitial fluid pressure":1,
"permeability":1,
"targeted delivery":1,
"In situ hybridization":1,
"Long non-coding RNA":1,
"MALAT1":1,
"RT-PCR":1,
"Anaplastic sarcoma of the kidney":1,
"DICER1":1,
"Pleuropulmonary blastoma":1,
"RNase III":1,
"Targeted therapy":2,
"endocrine surgical procedures":1,
"image-guided biopsy":1,
"single-site":1,
"three-port":1,
"cohort study":1,
"pharmacoepidemiology":1,
"prostate":1,
"spironolactone":1,
"histomorphological feature":1,
"idiopathic interstitial pneumonia":1,
"pulmonary adenocarcinoma":1,
"Decision tree analysis":1,
"Intraoperative cytology":1,
"Family papillary thyroid carcinoma (FPTC)":1,
"Frequency":1,
"Papillary thyroid carcinoma (PTC)":1,
"Statistical significance predisposition":1,
"Diagnóstico histológico":1,
"Factores predictivos":1,
"Glándula paratiroidea":1,
"Hipocalcemia":1,
"Hipoparatiroidismo":1,
"Histological diagnosis":1,
"Hypocalcemia":2,
"Hypoparathyroidism":1,
"Tiroidectomía":1,
"Leiomiosarcoma":1,
"Leiomyosarcoma":1,
"PET/TC":1,
"Tiroides":1,
"Uterus":1,
"Útero":1,
"Mnk":1,
"eIF4E":1,
"(177)Lu-DOTATATE":1,
"Cáncer de tiroides":2,
"Peptide receptor radionuclide Therapy":1,
"Radioactive iodine refractory":1,
"Refractario al yodo radiactivo":1,
"Tratamiento con análogos de la somatostatina radiomarcados":1,
"Breast cancer-specific survival":1,
"Calpain":1,
"Caspase":1,
"EGFR":1,
"FNAB":1,
"pregnancy":3,
"Cognitive changes":1,
"Culture":1,
"Symptoms":1,
"radiation exposure":1,
"nomogram":1,
"Notch":1,
"Notch3":1,
"Phosphatase and tensin homolog deleted on chromosome 10 (PTEN)":1,
"Phosphatidylinositol 3-kinase (PI3K)":1,
"Protein kinase B (AKT)":1,
"immunosuppression":1,
"long-term dialysis":1,
"solid organ transplantation":1,
"Chronic lymphocytic thyroiditis":1,
"Excellent response to therapy":1,
"Head and neck":1,
"Internal jugular vein":1,
"Tumor thrombosis":1,
"Tumor thrombus":1,
"Amenorrhea":1,
"Breast Neoplasms":1,
"head and neck radiotherapy":1,
"radiation dose volume histogram (DVH)":1,
"radiation toxicity":1,
"thyroid abnormality":1,
"Pituitary tumors":1,
"thyrotropinoma":1,
"FNAC":1,
"Multinodular goiter":1,
"fasting plasma glucose":1,
"waist circumference":1,
"Goiter":2,
"Raman spectroscopy":1,
"Autoimmune thyroid disease":1,
"Thyroglobulin antibodies":2,
"Thyroid peroxidase antibodies":1,
"Adolescent":1,
"Carcinome":1,
"Carcinome colorectal":1,
"Carcinome des glandes salivaires":1,
"Carcinome du sein":1,
"Carcinome indifférencié du nasopharynx":1,
"Colorectal carcinoma":1,
"Salivary gland carcinoma":1,
"Undifferentiated carcinoma of the nasopharyngeal tract":1,
"arytenoid adduction":1,
"recurrent nerve reconstruction":1,
"PD-1":1,
"pembrolizumab":1,
"thyroid dysfunction":1,
"Necrosis":1,
"Nipple-sparing mastectomy":1,
"Nipple–areolar complex":1,
"Aldehyde dehydrogenase":2,
"hypoxia-inducible factor-1α":1,
"Cystic lymph nodes":1,
"Cystic metastases":1,
"Melanoma":2,
"hidradenoma":1,
"oncocytic":1,
"Aldefluor assay":1,
"Spherogenicity":1,
"Glottis":1,
"Laryngeal Neoplasms":1,
"Practice Guideline":1,
"Supraglottis":1,
"Cervical lymphadenectomy":1,
"Functional neck dissection":1,
"Mini-incision":1,
"MAPK/JNK":1,
"PDX":1,
"endometrial cancer":1,
"kinase":1,
"lysosomes":1,
"postpartum thyroiditis":1,
"thyroid and pregnancy":1,
"thyroid function tests":1,
"False-negative rate":1,
"Fine-need aspiration biopsy":1,
"Nodular thyroid disease":1,
"Molecular analysis":1,
"N-RAS":1,
"molecular diagnostics":1,
"Familial cancer":1,
"HABP2":1,
"Novel variant":1,
"Biomarkers":1,
"VHL":1,
"non-invasive follicular thyroid neoplasms with papillary-like nuclear features":1,
"thyroid cytology":1,
"thyroid genetics":1,
"Data-dependent acquisition":1,
"Liquid chromatograph":1,
"Mass spectrometer":1,
"Metabolomics":1,
"Orbitrap":1,
"CGRP":1,
"gene knock-out":1,
"mouse genetics":1,
"parafollicular C cells":1,
"RNA seq analysis":1,
"epithelial-to-mesenchymal transition":1,
"thyroid side population":1,
"thyroid stem cells":1,
"Hypomagnesaemia":1,
"Continuous intraoperative neuromonitoring":1,
"Intraoperative neuromonitoring":1,
"Recurrent laryngeal nerve palsy":1,
"ALK gene rearrangement":1,
"ciliated muconodular papillary tumor":1,
"LI-RADS":1,
"hepatocellular carcinoma":4,
"octreoscan":1,
"unusual thyroid tumors":1,
"Anterior approach":1,
"Hepatectomy":1,
"Liver hanging maneuver":1,
"Biopsy, fine-needle":1,
"Diagnostic accuracy":1,
"Large nodules":1,
"8-OHdG":1,
"Graves's disease":1,
"Hashimoto thyroiditis":1,
"clinical and pathologic factors":1,
"disease progression":2,
"genomic alterations":1,
"risk index model":1,
"Diaphragm muscle paralysis":1,
"Nerve monitoring":1,
"Phrenic nerve":1,
"Vagus nerve":1,
"Her2":1,
"dual Her-2 blockade":1,
"Comprehensive genomic profiling":1,
"Fusion":1,
"Oncogene proteins":1,
"NF-κB":1,
"Hepatitic C virus":1,
"circadian clock":1,
"follicular thyroid malignancies":1,
"Cysts":1,
"Merkel cell":1,
"Metastatic squamous cell carcinoma":1,
"Neck":1,
"Tumor-like":1,
"Unknown primary":1,
"World Health Organization":1,
"Clear cell renal cell carcinoma":1,
"Tumor-to-tumor":1,
"Adolescents":2,
"Locoregional recurrence":1,
"Lymph node":2,
"Young adults":1,
"pathology":2,
"stroma":1,
"CBX7":1,
"Colon carcinoma":1,
"KRAS":1,
"miR-155":1,
"Prevalence":1,
"Sub-Saharan country":1,
"TIRADS":1,
"Thyroid incidentaloma":1,
"National Lung Screening Trial":1,
"incidental findings":1,
"low-dose CT":1,
"lung cancer screening":1,
"incidental":1,
"non-incidental thyroid carcinoma":1,
"Bone neoplasms":1,
"Pelvic bones":1,
"Horner’s syndrome":1,
"Malignant fibrous histiocytoma":1,
"Myxofibrosarcoma":1,
"Pancoast syndrome":1,
"Thyroid fine-needle aspiration biopsy":1,
"E2F8":1,
"Papillary thyroid cancer (PTC)":1,
"TCGA":1,
"miR-144":1,
"Pharmacogenetics":1,
"Signal pathways":1,
"Therapy":1,
"Lymph nodes":3,
"Lymphatic metastasis":1,
"Pyramidal":1,
"adolescent cancer":1,
"childhood cancer":1,
"costs and cost analysis":1,
"microRNA-146b":1,
"target gene":1,
"Head and neck neoplasms":2,
"Interleukin-17":2,
"MicroRNAs":1,
"thyroid cancer and volcanic environment":1,
"thyroid cancer epidemiology":1,
"Jugulo-omohyoid lymph nodes":1,
"Neoplasm metastasis, Lymph nodes":1,
"Super-selectiveneck dissection":1,
"18F-fluorodeoxyglugose Positron Emission Tomography with computed tomography":1,
"Algorithm":1,
"Malignancy risk":1,
"SUV":1,
"Thyroid incidentalomas":1,
"anxiety":1,
"decision making":1,
"radiation disaster":1,
"risk communication":1,
"self-condemnation":1,
"EPO":1,
"PADI2":1,
"pathway":1,
"multi-kinase inhibitors":1,
"sunitinib":1,
"Neuroendocrine Tumors":1,
"Neuroimaging":1,
"Cytotoxic chemotherapy":1,
"Drug therapy":1,
"Hyperglycemia":1,
"Mammalian target of rapamycin inhibitor":1,
"Neoplasms":1,
"Metabolism":1,
"expression levels":1,
"subtypes":1,
"Gastrointestinal stromal tumor":1,
"epithelial cells":1,
"human biology":1,
"medicine":1,
"protooncogenes":1,
"Toxicities":1,
"Aspartate aminotransferase-to-platelet ratio index":1,
"curative liver resection":1,
"extracellular-signal-regulated kinase 1/2/signal transducer and activator of transcription 3":1,
"hnRNPA2B1":1,
"tumorigenic potential":1,
"Endocrine surgery":1,
"Follicular thyroid carcinoma":1,
"Head and neck surgery":1,
"endocrine disruptors":1,
"environmental exposure":1,
"Follicular carcinoma of thyroid":1,
"intrathoracic mass":1,
"Airway stent":1,
"bronchoscopy":1,
"central airway obstruction":1,
"self-expanding metal stent":1,
"1810011o10 Rik":1,
"CD8+ T cells":1,
"Notch2":1,
"immunity":1,
"Cribriform carcinoma":1,
"TGF-β1":1,
"EWSR1-NR4A3":1,
"extraskeletal myxoid chondrosarcoma":1,
"next generation sequencing":1,
"SPC24":1,
"hobnail variant":1,
"molecular features":1,
"glucose":1,
"redifferentiation":1,
"Asistencia sanitaria":1,
"Consenso":1,
"Consensus":1,
"Ecografía tiroidea":1,
"Healthcare":1,
"Intervencionismo tiroideo":1,
"Minimally invasive therapies":1,
"Organización":1,
"Organization":1,
"Requirements":1,
"Requisitos":1,
"Thyroid ultrasound":1,
"B-Raf proto-oncogene serine/threonine kinase mutation":1,
"solitary papillary thyroid micro-carcinoma":1,
"clinical factors":1,
"immune response":1,
"interleukin-23":1,
"B-type Raf kinase V600E mutation":1,
"genetic features of thyroid cancer":1,
"lung adenocarcinomas":1,
"Lymphatic invasion":1,
"endocrinology":1,
"gene polymorphism":1,
"hormone":1,
"Thyroid cancer, papillary [Supplementary Concept]":1,
"Thyroid carcinoma, anaplastic":1,
"Cyclin D1":1,
"Cyclin-dependent kinase inhibitor p27":1,
"RET protein, human":1,
"struma ovarii":1,
"invasive thyroid cancer":1,
"Diabetes insipidus, central":1,
"Etiology":1,
"Pituitary gland, anterior":1,
"differentiated thyroid carcinoma, self-management":1,
"influencing factors":1,
"self efficacy":1,
"treatment strategy":1,
"Ap-2β":1,
"extrathyroidal extension":1,
"gender":1,
"hystotype":1,
"molecular analyses":1,
"prognostic factors":1,
"tumor size":1,
"Lung adenocarcinoma":1,
"Mutation analysis":1,
"Small cell lung cancer":1,
"Small cell transformation":1,
"TSH-suppressive therapy":1,
"intestinal malabsorption":1,
"Metastatic lymph node":1,
"Pazopanib":1,
"PHACE":1,
"endocrine":1,
"growth hormone":1,
"hypopituitarism":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年第1季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
